PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jargspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
J Assist Reprod Genet. 2003 February; 20(2): 58–62.
PMCID: PMC3455792

Correlation of NK Cell Activation and Inhibition Markers with NK Cytoxicity Among Women Experiencing Immunologic Implantation Failure After In Vitro Fertilization and Embryo Transfer

Abstract

Purpose: The pivotal event in determining successful from unsuccessful cycles after in vitro fertilization is implantation. The purpose of this study was to compare the percentage of circulating NK cells expressing activation and inhibition markers between infertile and fertile control women and to determine the correlation between these markers and those of the NK cytotoxicity activation assay. Lastly, we wish to determine the ability of each of these markers to predict pregnancy outcome after IVF/ET (in vitro fertilization/embryo transfer).

Methods: Blood samples from 22 infertile women undergoing IVF/ET during the November 2001 cycle were drawn on cycle Day 9 and analyzed for expression of CD69+, HLA-DR, CD161+, CD94+, and CD158a+ as well as NK cytotoxicity using immunoflluorescent labeling and flow cytometry. Results were compared with those from 26 fertile control women and correlated to pregnancy outcome that of cycle.

Results: Infertile women had significantly higher expression of NK cell activation markers of CD69+ and CD161+ than fertile women. NK cytotoxicity correlated inversely with expression of NK cells bearing the inhibition marker of CD94+. None of the successfully pregnant women of that cycle had elevated levels of NK cytotoxicity whereas 50% of those experiencing a chemical pregnancy loss and those not becoming pregnant had elevated levels of NK cytotoxicity.

Conclusions: Immunologic markers can identify mechanisms involved in implantation failure. Activation markers of CD69+ and CD161+ expressed on NK cells as well as NK cytotoxicity can be added to the previously reported risk factors for immunologic implantation failure.

Full Text

The Full Text of this article is available as a PDF (95K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194. [PubMed]
2. Coulam CB. Implantation failure and immunotherapy. Hum Reprod. 1995;10:1338–1340. [PubMed]
3. Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, development rates, and maternal age are correlated with chromosomal abnormalities. Fertil Steril. 1995;64:382–391. [PubMed]
4. Gianaroli L, Masgli C, Ferratetti AP, Munne S. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: Identification of the categories for which it should be proposed. Fertil Steril. 1999;72:837–844. [PubMed]
5. ASRM/SART Registry Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 2002;77:18–31. [PubMed]
6. King A, Loke YW. On the nature and function of human uterine granular lymphocytes. Immunol Today. 1991;12:432–435. [PubMed]
7. Clark DA, Vince G, Flanders K, Hirte H, Starkey P. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor beta 2 related immunosuppressive factors. Hum Reprod. 1994;9:2270–2277. [PubMed]
8. Michel M, Underwood J, Clark DA, Mowbray J, Beard RW. Histologic and immunologic study of uterine biopsy tissue of incipiently aborting women. Am J Obstet Gynecol. 1989;161:409–414. [PubMed]
9. Lea RG, Underwood J, Flanders KC, Hirte H, Banwatt D, Finotto S, Ohno I, Michel M, Daya S, Harley C, Mowbray JF, Clark DA. A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor beta 2 producing suppressor cells in decidua near the placental attachment site. Am J Reprod Immunol. 1995;34:52–61. [PubMed]
10. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KG. Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol. 1995;33:40–46. [PubMed]
11. Lachapelle MH, Miron P, Hemmings R, Roy DA. Endometrial T, B, and NK cells in patients with recurrent abortion: Altered profile and pregnancy outcome. J Immunol. 1996;156:4227–4234.
12. King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW. Uterine NK cells and trophoblast class I molecules. Am J Reprod Immunol. 1997;37:459–462. [PubMed]
13. Beer AE, Kwak JY, Ruiz JE. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol. 1996;35:376–382. [PubMed]
14. Roussev RG, Kaider BD, Price DE, Coulam CB. Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol. 1996;35:415–420. [PubMed]
15. Kaider AS, Kaider BD, Janowicz PB, Roussev RG. Immunologic evaluation in women with reproductive failure. Am J Reprod Immunol. 1999;42:335–346. [PubMed]
16. Coulam CB, Roussev RG. Chemical pregnancies: Immunologic and ultrsonographic studies. Am J Reprod Immunol. 2002;48:323–328. [PubMed]
17. Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y. Natural killer cell subpopulations and cytotoxicity for infertilepatients undergoing in vitro fertilization. Am J Reprod Immunol. 1999;41:413–422. [PubMed]
18. Clark DA, Lea RG, Podor T, Daya S, Banwatt D, Harley C. Cytokines determining the success or failure of pregnancy. Ann N Y Acad Sci. 1991;626:524–536. [PubMed]
19. Kane KL, Ashton FA, Schmitz JL, Folds JD. Determinations of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol. 1996;3:295–300. [PMC free article] [PubMed]
20. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer A. Status of peri-pheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod. 2001;16:855–861. [PubMed]
21. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14:353–356. [PubMed]
22. Raghupathy R. Th 1type immunity is incompatible with successful pregnancy. Immunol Today. 1997;18:478–482. [PubMed]
23. Coulam CB, Krysa LW, Bustillo M. Intravenous immunoglobulin for in vitro fertilization failure. Hum Reprod. 1994;9:2265–2269. [PubMed]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC